Alkami Technology enters the week with a sharply different complexion than it wore through the summer — shorts are retreating, options traders are bullish, and two activists are building positions even as the stock trades below most analyst targets.
The most striking development is the speed of the short-interest unwind. Shorts have cut roughly 22% of their position over the past month, with the float-adjusted short interest falling from around 7.4% to 5.7%. The move accelerated this week, down nearly 9.5% in five sessions. Meanwhile, the borrow market has opened up considerably. Availability has jumped from a tight 93% to 179% over the past two weeks — meaning there is now nearly twice as much lending supply as current demand. Cost to borrow is running at just 0.69%, a level that signals no meaningful stress in the lending pool. Together these data points describe covering shorts and loosening conditions, not fresh attacks.
Options positioning amplifies the constructive tone. The put/call ratio has collapsed to 0.32 — well below its 20-day average of 0.52 and close to the lowest reading of the past year. Call demand is driving the market, with the z-score sitting at -0.84. That's a meaningful rotation: as recently as late July, the PCR ran above 2.0, reflecting heavy downside hedging. The shift since then tracks with the stock's 4% weekly gain to $20.51, a 7.6% single-day move on September 11 underlining the change in momentum.
Two forces on the register are worth flagging. General Atlantic sits at 18.1% of shares outstanding on a Schedule 13D/A — an activist designation — after raising its stake from 16.3% in May. JANA Partners filed its own Schedule 13D in June at 6.3%, up from 4.99%, marking its third filing since April. Two named activists on the same register, both adding in 2026, is an unusual setup for a mid-cap software name. North Reef Capital also quietly expanded to 8.6% on a 13G/A filed in August. As always, 13D/G stakes are event-driven disclosures around the 5% threshold; positions are as last disclosed and can change without a further filing.
The Street has warmed noticeably since Q2 results in late July. JP Morgan lifted its target to $24 from $19 and Needham went to $25 from $22, both on August 24 — the most recent analyst actions on the name. The mean target now sits at $22, implying about 7% upside from the current price. The bull case centres on expanding AI-native product offerings and tailwinds from bank consolidation driving community institution demand. Bears point to SaaS revenue fragility in a tighter credit environment and concerns around execution after recent executive changes. Factor scores show the tension in compressed form: forward EPS momentum over 12 months ranks in the 94th percentile of the ORTEX universe, reflecting meaningful estimate revision higher — but the short score sits at 64.7, still elevated, and the EPS surprise rank is a weak 13th percentile, suggesting actual delivery has lagged raised expectations.
Peers registered a tough week in contrast. QTWO, BILL, and VERX all fell between 5% and 11%, as did FRSH and PRGS. ALKT's 4% gain against that backdrop is a genuine divergence, not just a rising tide. Whether that gap reflects the activist premium, the short-covering momentum, or something more fundamental is the question the October 28 earnings print will be asked to answer.
See the live data behind this article on ORTEX.
Open ALKT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
